TBRIF / Therma Bright highlights positive study results for partner Inretio's novel clot removal device for stroke treatment

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) told investors that Eric Myung has assumed the role of the company's new chief financial officer (CFO) with more_horizontal

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said that in the coming weeks, it expects a final decision on permanent codes from the Centers for Medicare more_horizontal

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has been engaged in discussions with the US Department of Health and Human Services (DHHS) over the more_horizontal

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF). announced that it has begun investigating opportunities to commercialize and monetize its artificial intel more_horizontal

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) along with its partner Inretio Inc has highlighted the successful completion of a Good Laboratory Practice more_horizontal

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) announced that it is working with its US distributor network on expanding sales of Venowave under the nine t more_horizontal

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) announced that it has established collaborations with several tuberculosis (TB) medical care facilities to i more_horizontal

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has successfully secured US Medicare and Medicaid reimbursement through various payers, with the rei more_horizontal